Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Outline
1. Seizure
2. Multiple Sclerosis
3. CNS Infection
4. Headache
5. Dementia
6. Movement Disorders
7. Peripheral Nervous System
8. Stroke
1.Seizure
Seizure
19
Pathogenesis
Inflammation, demyelination, and axon degeneration
cause of MS remains unknown
environment factor & susceptibility genes(HLA-DRB1*1501)
aberrant immune response
The most widely accepted theory
begins as an inflammatory autoimmune disorder mediated
by autoreactive T lymphocytes
EBV, HHV6
20
Clinical manifestation
Clinical isolated syndrome
Optic neuritis
EOM problemdiplopia
usually due to CN6 or INO
Internuclear ophthalmoplegia
bilateral INO is most suggestive of MS
21
Sensory symptoms
are a common initial feature of MS
numbness, tingling, pins-and-needles, tightness,
coldness, or swelling of the limbs or trunk
Trigeminal neuralgia in a young adult may be an early
sign of MS: 2%
22
Motor symptoms
Spasticity: 70% impairs mobility, disrupts sleep
Movement disorder
Tremor > tonic spasm
Coordination
Bowel/bladder/sexual function
most common urinary complaint is urgency
23
Heat sensitivity
Uhthoff phenomenon
small increases in the body temperature can temporarily
worsen current or preexisting signs and symptoms
24
25
28
Brain MRI
Dawson fingers
Others: T1,T2, enhancement
29
Spinal cord lesion:
more common in cervical
white matter in lateral & posterior column
typically < 2 vertebral segment, < ½ half cross-sectional
area
CSF:
Exclude other diagnosis
normal protein and WBC
35% not(lymphocytic pleocytosis)
Oligoclonal band (OCBs): 95%
IgG index > 0.7: 70~85%
VEP
30
For neurological progression suggestive of primary
progressive MS
the criteria require evidence of the one year of disease
progression plus two of the three following criteria
Dissemination in space in the brain
periventricular, juxtacortical, infratentorial, or spinal cord)
31
Treatment
Disease modifying drugs
Inteferon beta: first line for RRMS
side effect: flulike symptoms, injection site reactions, lab
abnormal(thrombocytopenia, anemia, leukopenia, increase liver
enzymes, thyroid dysfunction), worsen depression
Glatiramer acetate: first line for RRMS
side effect: injection site reaction, lipoatrophy, systemic reaction
Tysabri (natalizumab): 2nd line for RRMS
more effective than 1st line drugs, but with low risk of
PML(progressive multfocal leukoencephalopathy)
anti-natalizumab Ab loss of efficasy
Nitoxantrone : for SPMS
side effect: cardiotoxicity, leukemia, bone marrow suppression,
alopecia
No proven therapy for PPMS 32
Acute stage
High dose IV corticosteroid +- oral prednisolone (not affect long-
term outcome)
not affect degree of recovery
Plasma exchange
Symptomatic treatment
spaticity: baclofen(SE: limb weakness, sedation, confusion, seizure
or hallucination when abrupt discontinuation), tizanidine,
gabapentin, botulinum toxin
depression: lithium, depakin…
fatigue: other medical condition?(thyroid disease, anemia…),
amantadine, SSRI, methyprednisolone
overactive bladder: anticholinergic agents
MS tremor: rivotril, tegretol, keppra, gabapentin…
Paroxysmal symptoms: low dose AED
pain
constipation
33
3.CNS Infection
CNS Infection
CSF Study WBC Glucose Protein Pressure
(cell/mm )3 (mg/dl) (mg/dl) (cmH O)2
Virus ↑ = ↑ ↑
(lymphocyte)
Bacterial Meningitis